{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:33:48Z","timestamp":1759937628557},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00228-017-2382-4","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T12:15:50Z","timestamp":1511439350000},"page":"377-378","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Warfarin resistance from primidone in patient with essential tremor"],"prefix":"10.1007","volume":"74","author":[{"given":"Joseph P.","family":"Rindone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadwick K.","family":"Mellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"issue":"12","key":"2382_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","volume":"39","author":"WC Koller","year":"1989","unstructured":"Koller WC, Vetere-Overfield B (1989) Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 39(12):1587\u20131588. \nhttps:\/\/doi.org\/10.1212\/WNL.39.12.1587","journal-title":"Neurology"},{"issue":"2","key":"2382_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","volume":"10","author":"G Deuschl","year":"2011","unstructured":"Deuschl G, Raethjen J, Hellriegel H, Elble R (2011) Treatment of patients with essential tremor. Lancet Neurol 10(2):148\u2013161. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(10)70322-7","journal-title":"Lancet Neurol"},{"key":"2382_CR3","first-page":"1168","volume":"24","author":"AK Wittkowsky","year":"2004","unstructured":"Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O (2004) Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 24:1168\u20131674","journal-title":"Pharmacotherapy"},{"key":"2382_CR4","unstructured":"Package insert, primidone, Qualitest Pharmaceuticals 2010"},{"issue":"1","key":"2382_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00007691-198303000-00006","volume":"5","author":"D Battino","year":"1983","unstructured":"Battino D, Avanzini G, Bossi L, Croci D, Cusi C, Gomeni C, Moise A (1983) Plasma levels of primidone and its metabolite phenobarbital: effect of age and associated therapy. Ther Drug Monit 5(1):73\u201379. \nhttps:\/\/doi.org\/10.1097\/00007691-198303000-00006","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2382_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1124\/jpet.103.058818","volume":"308","author":"Y Chen","year":"2004","unstructured":"Chen Y, Ferguson SS, Negishi M, Goldstein JA (2004) Induction of human CYP2C9 by rifampicin, hyperforin and phenobarbital is medicated by pregnane X receptor. J Pharmacol Exp Ther 308(2):495\u2013501. \nhttps:\/\/doi.org\/10.1124\/jpet.103.058818","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2382_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/cpt196910180","volume":"10","author":"MG MacDonald","year":"1969","unstructured":"MacDonald MG, Robinson DS, Sylwester D, Jaffe JJ (1969) The effects of phenobarbital, choral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responses in man. Clin Pharmacol Ther 10(1):80\u201384. \nhttps:\/\/doi.org\/10.1002\/cpt196910180","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2382_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0002-9149(75)90560-3","volume":"35","author":"JA Udall","year":"1975","unstructured":"Udall JA (1975) Clinical implications of warfarin interactions with five sedatives. Am J Cardiol 35(1):67\u201371. \nhttps:\/\/doi.org\/10.1016\/0002-9149(75)90560-3","journal-title":"Am J Cardiol"},{"key":"2382_CR9","doi-asserted-by":"publisher","first-page":"107602961668784","DOI":"10.1177\/1076029616687849","volume":"1","author":"NP Clark","year":"2017","unstructured":"Clark NP, Hoang K, Delate T, Horn JR, Witt DM (2017) Warfarin interaction with hepatic cytochrome P-450 enzyme-inducing anticonvulsants. Clin Appl Thromb Hemost Jan 1:1076029616687849. \nhttps:\/\/doi.org\/10.1177\/1076029616687849","journal-title":"Clin Appl Thromb Hemost Jan"},{"issue":"4","key":"2382_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/archneur.56.4.475","volume":"56","author":"A Gironell","year":"1999","unstructured":"Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascuai-Sedano B (1999) A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 56(4):475\u2013480. \nhttps:\/\/doi.org\/10.1001\/archneur.56.4.475","journal-title":"Arch Neurol"},{"key":"2382_CR11","doi-asserted-by":"publisher","first-page":"CD009683","DOI":"10.1002\/14651858.CD009683.pub2","volume":"4","author":"E Bruno","year":"2017","unstructured":"Bruno E, Nicoletti A, Quattrocchi G, Allegra R, Filippini G, Colosimo C, Zappia M (2017) Topiramate for essential tremor. Cochrane Database Syst Rev 4:CD009683. \nhttps:\/\/doi.org\/10.1002\/14651858.CD009683.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2382_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eplepsyres.2016.06.003","volume":"126","author":"C Stollberger","year":"2016","unstructured":"Stollberger C, Finsterer J (2016) Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs. Epilepsy Res 126:98\u2013101. \nhttps:\/\/doi.org\/10.1016\/j.eplepsyres.2016.06.003","journal-title":"Epilepsy Res"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2382-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,10]],"date-time":"2018-02-10T00:35:26Z","timestamp":1518222926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2382-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2382-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]}}}